Browsing Tag
Mylan Specialty
2 posts
Is this Lupin’s next U.S. respiratory blockbuster? Generic Perforomist hits the shelves
Lupin launches generic Perforomist in the U.S. for asthma and COPD, eyeing a $268M market. Find out how this move boosts its global respiratory portfolio.
Alembic Pharmaceuticals gets FDA approval for Formoterol Fumarate Inhalation Solution
Alembic Pharmaceuticals said that it has secured final approval from the US Food and Drug Administration (FDA) for…